CAR T cells or allogeneic transplantation as standard of care for advanced large B-cell lymphoma: an intent-to-treat comparison
CD19-directed chimeric antigen receptor (CAR) T-cell treatment has evolved as standard of care (SOC) for multiply relapsed/refractory (R/R) large B-cell lymphoma (LBCL). However, its potential benefit over allogeneic hematopoietic cell transplantation (alloHCT) remains unclear. We compared outcomes...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
11 December 2020
|
| In: |
Blood advances
Year: 2020, Volume: 4, Issue: 24, Pages: 6157-6168 |
| ISSN: | 2473-9537 |
| DOI: | 10.1182/bloodadvances.2020003036 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/bloodadvances.2020003036
|
| Author Notes: | Peter Dreger, Sascha Dietrich, Maria-Luisa Schubert, Lorenz Selberg, Andrea Bondong, Mandy Wegner, Peter Stadtherr, Christoph Kimmich, Florentina Kosely, Anita Schmitt, Petra Pavel, Nora Liebers, Thomas Luft, Ute Hegenbart, Aleksandar Radujkovic, Anthony Dick Ho, Carsten Müller-Tidow, and Michael Schmitt |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1789178916 | ||
| 003 | DE-627 | ||
| 005 | 20230428191250.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220210s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1182/bloodadvances.2020003036 |2 doi | |
| 035 | |a (DE-627)1789178916 | ||
| 035 | |a (DE-599)KXP1789178916 | ||
| 035 | |a (OCoLC)1341441410 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Dreger, Peter |e VerfasserIn |0 (DE-588)1028891881 |0 (DE-627)732699894 |0 (DE-576)376320966 |4 aut | |
| 245 | 1 | 0 | |a CAR T cells or allogeneic transplantation as standard of care for advanced large B-cell lymphoma |b an intent-to-treat comparison |c Peter Dreger, Sascha Dietrich, Maria-Luisa Schubert, Lorenz Selberg, Andrea Bondong, Mandy Wegner, Peter Stadtherr, Christoph Kimmich, Florentina Kosely, Anita Schmitt, Petra Pavel, Nora Liebers, Thomas Luft, Ute Hegenbart, Aleksandar Radujkovic, Anthony Dick Ho, Carsten Müller-Tidow, and Michael Schmitt |
| 264 | 1 | |c 11 December 2020 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 10.02.2022 | ||
| 520 | |a CD19-directed chimeric antigen receptor (CAR) T-cell treatment has evolved as standard of care (SOC) for multiply relapsed/refractory (R/R) large B-cell lymphoma (LBCL). However, its potential benefit over allogeneic hematopoietic cell transplantation (alloHCT) remains unclear. We compared outcomes with both types of cellular immunotherapy (CI) by intention to treat (ITT). Eligble were all patients with R/R LBCL and institutional tumor board decision recommending SOC CAR T-cell treatment between July 2018 and February 2020, or alloHCT between January 2004 and February 2020. Primary end point was overall survival (OS) from indication. Altogether, 41 and 60 patients for whom CAR T cells and alloHCT were intended, respectively, were included. In both cohorts, virtually all patients had active disease at indication. CI was recommended as part of second-line therapy for 21 alloHCT patients but no CAR T-cell patients. Median OS from indication was 475 days with CAR T cells vs 285 days with alloHCT (P = .88) and 222 days for 39 patients for whom alloHCT beyond second line was recommended (P = .08). Of CAR T-cell and alloHCT patients, 73% and 65%, respectively, proceeded to CI. After CI, 12-month estimates for nonrelapse mortality, relapse incidence, progression-free survival, and OS for CAR T cells vs alloHCT were 3% vs 21% (P = .04), 59% vs 44% (P = .12), 39% vs 33% (P = .97), and 68% vs 54% (P = .32), respectively. In conclusion, CAR T-cell outcomes were not inferior to alloHCT outcomes, whether measured by ITT or from CI administration, supporting strategies preferring CAR T cells over alloHCT as first CI for multiply R/R LBCL. | ||
| 700 | 1 | |a Dietrich, Sascha |d 1979- |e VerfasserIn |0 (DE-588)136406300 |0 (DE-627)694354635 |0 (DE-576)301003408 |4 aut | |
| 700 | 1 | |a Schubert, Maria-Luisa |d 1982- |e VerfasserIn |0 (DE-588)1147867631 |0 (DE-627)1007273801 |0 (DE-576)49608089X |4 aut | |
| 700 | 1 | |a Selberg, Lorenz |d 1990- |e VerfasserIn |0 (DE-588)1240718985 |0 (DE-627)1769551816 |4 aut | |
| 700 | 1 | |a Bondong, Andrea |e VerfasserIn |0 (DE-588)106584851X |0 (DE-627)816875502 |0 (DE-576)425539857 |4 aut | |
| 700 | 1 | |a Wegner, Mandy |e VerfasserIn |0 (DE-588)1251493033 |0 (DE-627)1789183243 |4 aut | |
| 700 | 1 | |a Stadtherr, Peter |e VerfasserIn |0 (DE-588)1065847971 |0 (DE-627)816874557 |0 (DE-576)425538737 |4 aut | |
| 700 | 1 | |a Kimmich, Christoph |e VerfasserIn |0 (DE-588)1075478413 |0 (DE-627)833305042 |0 (DE-576)443499632 |4 aut | |
| 700 | 1 | |a Kosely, Florentina |d 1981- |e VerfasserIn |0 (DE-588)104461921X |0 (DE-627)772248486 |0 (DE-576)397987943 |4 aut | |
| 700 | 1 | |a Schmitt, Anita |d 1969- |e VerfasserIn |0 (DE-588)141722495 |0 (DE-627)630587752 |0 (DE-576)325593892 |4 aut | |
| 700 | 1 | |a Pavel, Petra |e VerfasserIn |0 (DE-588)1220814466 |0 (DE-627)1737786850 |4 aut | |
| 700 | 1 | |a Liebers, Nora |d 1989- |e VerfasserIn |0 (DE-588)1123162875 |0 (DE-627)879999578 |0 (DE-576)481643850 |4 aut | |
| 700 | 1 | |a Luft, Thomas |e VerfasserIn |0 (DE-588)1078976309 |0 (DE-627)839996969 |0 (DE-576)452120659 |4 aut | |
| 700 | 1 | |a Hegenbart, Ute |e VerfasserIn |0 (DE-588)1028373708 |0 (DE-627)73062157X |0 (DE-576)35901903X |4 aut | |
| 700 | 1 | |a Radujković, Aleksandar |d 1980- |e VerfasserIn |0 (DE-588)132951320 |0 (DE-627)529183536 |0 (DE-576)299523721 |4 aut | |
| 700 | 1 | |a Ho, Anthony Dick |d 1948- |e VerfasserIn |0 (DE-588)108692477 |0 (DE-627)504904205 |0 (DE-576)19010466X |4 aut | |
| 700 | 1 | |a Müller-Tidow, Carsten |d 1968- |e VerfasserIn |0 (DE-588)1015101798 |0 (DE-627)705330230 |0 (DE-576)351197893 |4 aut | |
| 700 | 1 | |a Schmitt, Michael |d 1966- |e VerfasserIn |0 (DE-588)133177173 |0 (DE-627)538000600 |0 (DE-576)299672921 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood advances |d Washington, DC : American Society of Hematology, 2016 |g 4(2020), 24, Seite 6157-6168 |h Online-Ressource |w (DE-627)873588312 |w (DE-600)2876449-3 |w (DE-576)48043249X |x 2473-9537 |7 nnas |a CAR T cells or allogeneic transplantation as standard of care for advanced large B-cell lymphoma an intent-to-treat comparison |
| 773 | 1 | 8 | |g volume:4 |g year:2020 |g number:24 |g pages:6157-6168 |g extent:12 |a CAR T cells or allogeneic transplantation as standard of care for advanced large B-cell lymphoma an intent-to-treat comparison |
| 856 | 4 | 0 | |u https://doi.org/10.1182/bloodadvances.2020003036 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220210 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 133177173 |a Schmitt, Michael |m 133177173:Schmitt, Michael |d 910000 |d 910100 |e 910000PS133177173 |e 910100PS133177173 |k 0/910000/ |k 1/910000/910100/ |p 18 |y j | ||
| 998 | |g 1015101798 |a Müller-Tidow, Carsten |m 1015101798:Müller-Tidow, Carsten |d 910000 |d 910100 |e 910000PM1015101798 |e 910100PM1015101798 |k 0/910000/ |k 1/910000/910100/ |p 17 | ||
| 998 | |g 108692477 |a Ho, Anthony Dick |m 108692477:Ho, Anthony Dick |d 910000 |d 910100 |e 910000PH108692477 |e 910100PH108692477 |k 0/910000/ |k 1/910000/910100/ |p 16 | ||
| 998 | |g 132951320 |a Radujković, Aleksandar |m 132951320:Radujković, Aleksandar |d 910000 |d 910100 |d 50000 |e 910000PR132951320 |e 910100PR132951320 |e 50000PR132951320 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 15 | ||
| 998 | |g 1028373708 |a Hegenbart, Ute |m 1028373708:Hegenbart, Ute |d 910000 |d 910100 |d 50000 |e 910000PH1028373708 |e 910100PH1028373708 |e 50000PH1028373708 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 14 | ||
| 998 | |g 1078976309 |a Luft, Thomas |m 1078976309:Luft, Thomas |d 910000 |d 910100 |d 50000 |e 910000PL1078976309 |e 910100PL1078976309 |e 50000PL1078976309 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 13 | ||
| 998 | |g 1123162875 |a Liebers, Nora |m 1123162875:Liebers, Nora |d 910000 |d 910100 |e 910000PL1123162875 |e 910100PL1123162875 |k 0/910000/ |k 1/910000/910100/ |p 12 | ||
| 998 | |g 141722495 |a Schmitt, Anita |m 141722495:Schmitt, Anita |d 910000 |d 910100 |d 50000 |e 910000PS141722495 |e 910100PS141722495 |e 50000PS141722495 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 10 | ||
| 998 | |g 104461921X |a Kosely, Florentina |m 104461921X:Kosely, Florentina |p 9 | ||
| 998 | |g 1075478413 |a Kimmich, Christoph |m 1075478413:Kimmich, Christoph |d 910000 |d 910100 |e 910000PK1075478413 |e 910100PK1075478413 |k 0/910000/ |k 1/910000/910100/ |p 8 | ||
| 998 | |g 1065847971 |a Stadtherr, Peter |m 1065847971:Stadtherr, Peter |d 910000 |d 910100 |e 910000PS1065847971 |e 910100PS1065847971 |k 0/910000/ |k 1/910000/910100/ |p 7 | ||
| 998 | |g 1251493033 |a Wegner, Mandy |m 1251493033:Wegner, Mandy |d 910000 |e 910000PW1251493033 |k 0/910000/ |p 6 | ||
| 998 | |g 1240718985 |a Selberg, Lorenz |m 1240718985:Selberg, Lorenz |d 50000 |e 50000PS1240718985 |k 0/50000/ |p 4 | ||
| 998 | |g 1147867631 |a Schubert, Maria-Luisa |m 1147867631:Schubert, Maria-Luisa |d 910000 |d 910100 |e 910000PS1147867631 |e 910100PS1147867631 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 136406300 |a Dietrich, Sascha |m 136406300:Dietrich, Sascha |d 910000 |d 910100 |e 910000PD136406300 |e 910100PD136406300 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 1028891881 |a Dreger, Peter |m 1028891881:Dreger, Peter |d 910000 |d 910100 |e 910000PD1028891881 |e 910100PD1028891881 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1789178916 |e 4055463227 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Peter Dreger, Sascha Dietrich, Maria-Luisa Schubert, Lorenz Selberg, Andrea Bondong, Mandy Wegner, Peter Stadtherr, Christoph Kimmich, Florentina Kosely, Anita Schmitt, Petra Pavel, Nora Liebers, Thomas Luft, Ute Hegenbart, Aleksandar Radujkovic, Anthony Dick Ho, Carsten Müller-Tidow, and Michael Schmitt"]},"recId":"1789178916","note":["Gesehen am 10.02.2022"],"origin":[{"dateIssuedDisp":"11 December 2020","dateIssuedKey":"2020"}],"language":["eng"],"person":[{"role":"aut","display":"Dreger, Peter","given":"Peter","family":"Dreger"},{"display":"Dietrich, Sascha","role":"aut","family":"Dietrich","given":"Sascha"},{"role":"aut","display":"Schubert, Maria-Luisa","given":"Maria-Luisa","family":"Schubert"},{"family":"Selberg","given":"Lorenz","display":"Selberg, Lorenz","role":"aut"},{"display":"Bondong, Andrea","role":"aut","family":"Bondong","given":"Andrea"},{"family":"Wegner","given":"Mandy","display":"Wegner, Mandy","role":"aut"},{"role":"aut","display":"Stadtherr, Peter","given":"Peter","family":"Stadtherr"},{"role":"aut","display":"Kimmich, Christoph","given":"Christoph","family":"Kimmich"},{"given":"Florentina","family":"Kosely","role":"aut","display":"Kosely, Florentina"},{"display":"Schmitt, Anita","role":"aut","family":"Schmitt","given":"Anita"},{"family":"Pavel","given":"Petra","display":"Pavel, Petra","role":"aut"},{"role":"aut","display":"Liebers, Nora","given":"Nora","family":"Liebers"},{"display":"Luft, Thomas","role":"aut","family":"Luft","given":"Thomas"},{"given":"Ute","family":"Hegenbart","role":"aut","display":"Hegenbart, Ute"},{"role":"aut","display":"Radujković, Aleksandar","given":"Aleksandar","family":"Radujković"},{"given":"Anthony Dick","family":"Ho","role":"aut","display":"Ho, Anthony Dick"},{"role":"aut","display":"Müller-Tidow, Carsten","given":"Carsten","family":"Müller-Tidow"},{"family":"Schmitt","given":"Michael","display":"Schmitt, Michael","role":"aut"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1789178916"],"doi":["10.1182/bloodadvances.2020003036"]},"physDesc":[{"extent":"12 S."}],"relHost":[{"title":[{"title":"Blood advances","title_sort":"Blood advances"}],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"note":["Gesehen am 27.04.21"],"disp":"CAR T cells or allogeneic transplantation as standard of care for advanced large B-cell lymphoma an intent-to-treat comparisonBlood advances","name":{"displayForm":["American Society of Hematology"]},"pubHistory":["Vol. 1, iss. 1 (November 2016)-"],"part":{"year":"2020","extent":"12","volume":"4","text":"4(2020), 24, Seite 6157-6168","issue":"24","pages":"6157-6168"},"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"zdb":["2876449-3"],"issn":["2473-9537"],"eki":["873588312"]},"origin":[{"publisherPlace":"Washington, DC","dateIssuedDisp":"[2016]-","publisher":"American Society of Hematology"}],"recId":"873588312"}],"title":[{"subtitle":"an intent-to-treat comparison","title":"CAR T cells or allogeneic transplantation as standard of care for advanced large B-cell lymphoma","title_sort":"CAR T cells or allogeneic transplantation as standard of care for advanced large B-cell lymphoma"}]} | ||
| SRT | |a DREGERPETECARTCELLSO1120 | ||